Type 1 diabetes is a life-long autoimmune disease with onset in early childhood. The diagnosis will initially turn the everyday life of children and their families topsy-turvy due to blood glucose testing, insulin injections, thorough calculation of meals, etc. It takes time before all these new and often frightening procedures become part of the daily routine of small diabetics.
Vienna, Austria 30 September - 2 October
In recent years wound management has been primarily nurse-led, and not benefited from a multi-disciplinary approach. This must change, said Madeleine Flanagan, Principal Lecturer at the University of Hertfordshire's school of Post Graduate Medicine in the faculty of health and human science, where she runs the MSc in Dermatology and an MSc in Skin Integrity; she is also Principal of the European…
This April, scientists, physicians, nurses, diabetes organisation heads, patients and representatives from Bayer HealthCare Diabetes Care gathered in Basel, Switzerland, for the third European Media Workshop on Diabetes. The event was hosted by Bayer HealthCare Diabetes Care, which is celebrating 40 years of innovative blood glucose monitoring.
A telemedicine programme, run through Leicester University Hospitals since last November, allows parents and young patients with Type 1 diabetes to use their mobile phone to record blood sugar levels.
The Wound Care Unit at the Clinic Pasteur in Toulouse, France, was successfully set up to deliver a multidisciplinary approach to diabetic wound care.
Professor Rudolf A Weiner, head of the surgical department at Sachsenhausen Hospital, Germany, reports that some developing procedures result not only result in weight loss but also in the systematic elimination of metabolic disorders, and that many new developments in the field promise hope for both the obese and their doctors
Healthcare services often do not reach the target groups because socio-cultural preferences and values of patients and their relatives are not properly considered.
Among 2,552 European R&D projects (clinical phases I-III) conducted by small and mid-size biotechnology firms (under 600 employees), 64 are focused on diabetes, according to a large, detailed study carried out by Novumed Life Science Consulting.
The hugely increasing numbers of diabetics is a medical and financial burden worldwide. Diabetics can, for example, suffer eye and kidney problems and more - five percent of them develop vascular diseases, leading to lower limb and feet ulcerations, which frequently result in amputations if not treated in time. Percutaneous transluminal angioplasty (PTA) can heal ulcers and, because it is…
A study published by the Journal of the American Medical Association (JAMA) recently has found that those with type 2 diabetes who had a diet high in low-glycemic foods such as nuts, beans and lentils had greater improvement in glycemic control and risk factors for coronary heart disease than those on a diet with an emphasis on high-cereal fibre.
Das Center for Cardiovaskular Research (CCR) an der Berliner Charité konnte sich durch vielseitige Grundlagenforschung über die deutschen Landesgrenzen hinaus bereits einen Namen machen. Nun stellt das CCR in einem aktuellen Zwischen- bericht unter anderem vielversprechende Ent- wicklungen einer neuen Medikamentenklasse bei Endorganschäden und die Erforschung der Blutgefäßbildung bei…
In a strategic move intended to enhance the global launch of its 'groundbreaking' diabetes monitoring device, set to help combat the 'worldwide epidemic', the US company Sensys Medical has chosen to relocate its world headquarters to the United Kingdom (UK).
The 2nd international symposium `Diabetic foot: surgery, therapy, rehabilitation´ took place on the beginning of October in St. Petersburg. Olga Ostrovskaya reports from Russia
A panel of experts, convened by the American Diabetes Association and the European Association for the Study of Diabetes, has issued updated treatment recommendations for type 2 diabetes, in a consensus statement published online in two journals: Diabetes Care and Diabetologia*.
There's little evidence that newer, more expensive drugs work any better than older, cheaper medications. Diabetes, which came 7th in the list of the USA's top mortality causes in 2006, has hit a new high.
Diabetes presents a special challenge for the young. Here we see how a young Swiss girl has successfully come to terms with her metabolic disorder. A true life story from Bayer HealthCare Diabetes Care (BayNews)
When from 19 to 22 November the world's largest medical fair takes place in Dusseldorf, the entire city is in a kind of emergency state: hotels are bustin' out of their seams, traffic periodically comes to a standstill and at night exhibitors and visitors alike crowd the narrow streets of the Altstadt and the fancy hotel bars and enjoy whatever entertainment North Rhine-Westphalia's capital has…
Die erste am Universitätsklinikum Carl Gustav Carus vorgenommene Transplantation von Inselzellen aus einer Bauchspeicheldrüse verlief erfolgreich: Zwei Wochen nach dem Eingriff bildet die seit 51 Jahren an Diabetes Typ 1 erkrankte Patientin wieder körpereigenes Insulin. Die Transplantation ist Ergebnis einer über zwei Jahre dauernden, aufwendigen Aufbauarbeit an Uniklinikum und Medizinischer…
The next flu season will come. To prevent high-risk people from infections, the National Institute for Health and Clinical Excellence (NICE) recently published a final guidance on the use of the drugs oseltamivir, amantadine and zanamivir for the prophylaxis of influenza. "But vaccination is the main way to prevent flu", says Gillian Leng, NICE Deputy Chief Executive.
At the opening of the Johnson & Johnson Diabetes Institute in Paris experts took the opportunity to warn against the growing incidence of diabetes. They reinforced the believe that improved education measures as a key enabler for patients to better manage the condition. They predicted that in 2025 the number of people with diabetes wil have increased by 20 percent in Europe.
Good news for diabetes patients in the UK: According to a report published recently by the Department of Health, diabetes care in the NHS is improving and focusing more on prevention. The result: More patients have been identified, and in more people at risk development of the condition could be prevented.
Yes, it is, according to a prospective cohort study published in CMAJ. The study was conducted by researchers from the Hong Kong Institute of Diabetes and Obesity, the Li Ka Shing Institute of Health Science and The Chinese University of Hong Kong. Their result: A V-shaped risk relation between LDL cholesterol and cancer in patients not receiving statin therapy.
People with diabetes are often interested to be involved in research trials, according to the patient organization UK Diabetes. Therefore, the Diabetes Research Network (DRN) announced an initiative which shall help diabetics to play a greater role in research.
Researchers have discovered a potential new treatment for diabetes by isolating and killing defective cells which prevent the natural production of insulin. The investigation opens the door to a potential therapy for patients with type 1 diabetes.
